ZENOBE GRAMME CERT (ZEN) Share Price

This is thin to .2 cents on level 2

32m bidding. No fills

PDSB $21 target just out, stock reversing: DJ PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright

Don't forget the commissions ($6.95 on Schwab - lol)

ISPC.......CHEK,,,,,,,SPGC.......FOXO......................https://stockcharts.com/h-sc/ui?s=CHEK&p=D&yr=0&mn=3&dy=0&id=p11960084343

RS is not on the table and only being talked about with losers that probably sold out and now want back in. Filings should be out shortly and with MILLIONS in REVs showing these TRIP shares will be a thing of the past.

If you mean, "at what point in the review process are negative outcomes determined?", then I think the answer is "at the very end". Companies do withdraw their applications of course - probably at CS2 - but denials seem to come out after both clock stops have passed.

I agree that n

JohnnyDollar,

You’ve hit on a critical point. Otterman once pushed for revocation, claiming it was the “economical” choice. But let’s break that down:

1️⃣ Revocation wipes out all shareholders—so if Otterman was truly a shareholder, why would he advocate for total destr

Were is pumper pimp Crawfors as the stock slides deeper.

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

Meanwhile, the protests outside the same Republican congressman's town hall meeting

https://x.com/ArtCandee/status/1894077017747750967

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

Seems to be holding the 200 day MA ($53.07) and well above the 50 day MA ($35.65),..with that 50 day MA increasing rapidly, soon to overtake the 200 day MA. As for CVNA, well, yes, it's down today, but look at the 1 year chart. Very much on an upward trend, moving between the 50 day and 200 day MA.

I don't believe what's said on phone anymore .
Why don't you get it in an email and then tell us . 

LITM .42 gtc filled...nice!!

Good afternoon everyone! HMBL has been reset at RSI level 25 on Friday at close. Let's go

Bashers aren’t getting my shares.😎 ASII LONG💰

https://investorshub.advfn.com/uimage/uploads/2024/11/15/deimvIMG_0402.jpeg

All the paid bashers of IFUS except 2 clowns have been pretty quiet

Uber last posted on Dec 18th when he guaranteed IFUS would be sub penny

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175548990

Pantherj/kitty/pinocchio has not posted h

IMMUNO NEWS: $ESLA @ $1.30s: Volume precedes price...Volume & price. Up over last few sessions. Given $16 target last week by big bio/pharma ETF.. Revolutionary immuno bio/pharma play. Made huge gains on $IOVA & holding $APVO too.
$ESLA Powering up. News link:
9/29/24
https://f

STTK BUILDING MOMO

Will need to be a bit higher
. . . Mexedia S.p.A., a leading telecommunications and technology company listed on Euronext Growth in Paris, has completed the acquisition of its U.S. and Irish operational units by the U.S.-based Raadr Inc. (listed on OTC Markets). The transaction was complet

"So many variables and permutations that the commons could be near worthless to north of $200/share (no srs or warrants/no cap raise)."

So, you're the driver of the MANURE WAGON. Worst case scenario, commons will still own 20.1% of the corporations. And you think that is "near worthle